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Purpose of the study
HIV-1 enters target cells by binding to the CD4 molecule
and a co-receptor (CCR5 [R5] and/or CXCR4 [X4]). HIV-
1 may be classified as R5-tropic, X4-tropic, or dual/mixed
(D/M) tropic depending on the co-receptor(s) used. Little
is known about the prevalence of R5-tropic HIV-1 in
regions of the world where non-clade B virus predomi-
nates. The objectives of this study were to determine the
prevalence of R5-tropic HIV-1 amongst treatment-experi-
enced (TE) individuals in South Africa infected with Clade
C virus (the predominant Clade in South Africa) and to
ascertain variables associated with R5 tropism.
Methods
At a single study visit, in this cross-sectional study con-
ducted at three sites in South Africa, a brief questionnaire
elicited information on demographics, HIV clinical his-
tory, and antiretroviral regimens. Blood was drawn from
subjects and analyzed for CD4 cell count, HIV-1 RNA load
(VL), and HIV-1 genotype to ascertain clade. Clade C sam-
ples with a VL of >1,000 copies/mL were tested for tro-
pism via the original phenotypic Trofile™ assay.
Summary of results
Of the 353 subjects recruited for this study, 294 (84.2%)
had a VL of >1,000 copies/mL; 276 (93.9%) of these were
infected with Clade C HIV-1. Tropism results were
obtained for 206 (74.6%) subjects with Clade C HIV-1.
Mean age at study entry was 37 years; 40.8% of subjects
were male, and the majority (97.6%) were of African race/
ethnicity. Most (98.1%) subjects reported a heterosexual
mode of HIV-1 transmission. Mean VL was 122,978 cop-
ies/mL and mean CD4 cell count was 208 cells/μL. R5, D/
M and X4-tropic HIV-1 was present in 146 (70.9%), 52
(25.2%) and 8 (3.9%) of TE subjects, respectively. A mul-
tivariate logistic model was fitted including age, sex, CD4
cell count, VL, time since HIV diagnosis, and mode of HIV
transmission. Backward selection from a saturated model
with all two-way interactions yielded three variables sig-
nificantly associated with R5 tropism: age, VL, and CD4
cell count.
Conclusion
R5-tropic HIV-1 was the predominant variant detected in
this TE South African population infected with Clade C
HIV-1. In a multivariate model, older age, higher CD4 cell
count, and higher VL were all associated with the presence
of R5 co-receptor usage.
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